Signs of mold toxicity mirror symptoms of common health nuisances...but a nationally recognized mold remediator says exposure ...
This could be partly attributed to an increase in focus on using RNA-based therapies for rare disease treatment.
PEMGARDA (pemivibart) net product revenue of $13.8 million, 48% growth over Q3 2024 net product revenue of $9.3 millionPreliminary Q4 2024 total operating costs and expenses of approximately ...
The adoption of telemedicine and remote monitoring technologies in ophthalmology to accelerate the market growth, says Fact.MR in its new market research report.Rockville, MD, Feb. 03, 2025 (GLOBE ...
The Nation Newspaper 'Underage mothers, diseases, delayed healthcare access contributing to maternal mortality in Nigeria' ...